Vitamin D and plasma cell dyscrasias: reviewing the significance

Annals of Hematology
Nicholas Burwick

Abstract

Monoclonal gammopathy of undetermined significance (MGUS) is a clonal plasma cell disorder and precursor disease to multiple myeloma and other related cancers. While MGUS is considered a benign disorder, with a low risk of disease progression, patients have altered bone microarchitecture and an increased risk of bone fracture. In addition, alterations in immune function are regularly found to correlate with disease activity. Vitamin D, an important hormone for bone and immune health, is commonly deficient in multiple myeloma patients. However, vitamin D deficiency is also prevalent in the general population. The purpose of this review is to highlight the current understanding of vitamin D in health and disease and to parallel this with a review of the abnormalities found in plasma cell dyscrasias. While some consensus statements have advocated for vitamin D testing and routine supplementation in MGUS, there is no clear standard of care approach and clinical practice patterns vary. Further research is needed to better understand how vitamin D influences outcomes in MGUS patients.

References

Sep 1, 1990·European Journal of Haematology·A OsterborgH Mellstedt
Mar 1, 1991·The Journal of Clinical Investigation·J M Lemire, D C Archer
Jul 23, 1996·Proceedings of the National Academy of Sciences of the United States of America·M T CantornaH F DeLuca
Feb 29, 2000·The Journal of Immunology : Official Journal of the American Association of Immunologists·G Penna, L Adorini
Apr 25, 2000·Biochemical and Biophysical Research Communications·M D GriffinR Kumar
Apr 26, 2000·The Journal of Immunology : Official Journal of the American Association of Immunologists·L PiemontiV Di Carlo
Dec 26, 2003·The New England Journal of Medicine·Erming TianJohn D Shaughnessy
Feb 3, 2004·Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research·L Joseph MeltonRobert A Kyle
Mar 5, 2005·Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research·L Joseph MeltonS Vincent Rajkumar
May 5, 2005·JAMA : the Journal of the American Medical Association·Jane A CauleySteven R Cummings
Nov 25, 2005·Pharmacotherapy·George R BailieUNKNOWN National Kidney Foundation
Mar 31, 2006·The New England Journal of Medicine·Robert A KyleL Joseph Melton
Aug 24, 2006·British Journal of Haematology·Henrik GregersenMette Nørgaard
Sep 13, 2006·Leukemia & Lymphoma·Ombretta AnnibaliGiuseppe Avvisati
Dec 21, 2006·JAMA : the Journal of the American Medical Association·Kassandra L MungerAlberto Ascherio
Apr 12, 2007·The Journal of Clinical Endocrinology and Metabolism·N BinkleyM K Drezner
Jul 20, 2007·The New England Journal of Medicine·Michael F Holick
Jul 21, 2007·The Journal of Immunology : Official Journal of the American Association of Immunologists·Sheng ChenPeter E Lipsky
Sep 18, 2007·Medical Oncology·Vladimir JurisicMilica Colovic
Nov 8, 2007·The Journal of Clinical Endocrinology and Metabolism·Marian T HannanMichael F Holick
May 20, 2008·British Journal of Haematology·Ashraf BadrosElizabeth Streeten
Jun 20, 2008·Kidney International·Thomas L NickolasElizabeth Shane
Aug 7, 2008·Cancer·Pellegrino MustoUNKNOWN GIMEMA (Italian Group for Adult Hematologic Diseases)/Multiple Myeloma Working Party and the Italian Myeloma Network
Oct 3, 2008·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·James R BerensonRegina A Swift
Feb 24, 2009·Blood·Brendan M WeissW Michael Kuehl
Mar 25, 2009·Archives of Internal Medicine·Adit A GindeCarlos A Camargo
Apr 30, 2010·Current Opinion in Pharmacology·Femke BaekeChantal Mathieu
Dec 2, 2010·The Journal of Clinical Endocrinology and Metabolism·A Catharine RossSue A Shapses
Dec 7, 2010·Lancet·Gareth J MorganUNKNOWN National Cancer Research Institute Haematological Oncology Clinical Study Group
Feb 12, 2011·Nutrition Research·Kimberly Y Z Forrest, Wendy L Stuhldreher
Jun 8, 2011·The Journal of Clinical Endocrinology and Metabolism·Michael F HolickUNKNOWN Endocrine Society

❮ Previous
Next ❯

Citations

May 21, 2020·Blood Advances·Molly WentRichard S Houlston
Jun 23, 2019·Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer·Karthik NathGeorgina Hodges
Jan 25, 2020·Journal of Bone and Mineral Metabolism·Guillermina OrdunaAdolfo Díez-Pérez
Jun 3, 2021·International Journal of Molecular Sciences·Vanessa InnaoSebastiano Gangemi

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.